Article Text

Download PDFPDF
CASE REPORT
Primary central nervous system plasmablastic lymphoma in an HIV-positive patient
  1. Ruben Rhoades1,
  2. Jerald Gong2,
  3. Neil Palmisiano1 and
  4. Onder Alpdogan1
  1. 1 Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
  2. 2 Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Ruben Rhoades, ruben.rhoades{at}jefferson.edu

Abstract

Plasmablastic lymphoma (PBL) is a rare subtype of diffuse large B-cell lymphoma, highly associated with HIV and Epstein-Barr virus (EBV) infections. It commonly presents in extranodal sites, often an oral mass, but reports of primary central nervous system PBL (PCNSPBL) are exceedingly rare. Here, we report on a 33-year-old man with newly diagnosed HIV infection who presented with acute-onset unilateral visual disturbance and was found to have biopsy-proven PCNSPBL. The neoplastic cells displayed a plasmacytoid appearance, with the expression of CD38 and CD138, and were positive for EBV by in situ hybridisation for EBV-encoded RNA. Systemic workup revealed the presence of Kaposi sarcoma, but no evidence of lymphoma. He is currently being treated with high-dose methotrexate, as well as antiretroviral therapy for his HIV infection, and has achieved a complete response.

  • CNS cancer
  • malignant and benign haematology
  • HIV / AIDS
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors Primary author was RR. OA, NP, and JG contributed equally to the preparation and editing of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.